BNP Paribas Financial Markets
ONCR

BNP Paribas Financial Markets’s Oncorus, Inc. ONCR Stock Holding History

BNP Paribas Financial Markets’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-905
Closed -$769 – 4852
2022
Q3 		$769 Buy
+905
New +$1.16K ﹤0.01% 4471

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BNP Paribas Financial Markets's ONCR Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Oncorus, Inc. (ONCR) in Q4 2022, closing a stake of 905 shares — an estimated $769 sold.

BNP Paribas Financial Markets first reported a position in ONCR in Q3 2022 and held it in 1 quarter. The position peaked at $769 in Q3 2022. 33 funds tracked by Wall St. Rank hold ONCR as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Oncorus, Inc. position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 905 Oncorus, Inc. shares in Q4 2022, an estimated $769.
  • BNP Paribas Financial Markets first reported a position in Oncorus, Inc. in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Oncorus, Inc. position peaked at $769 in Q3 2022.
  • 33 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.